Q&A
Biotech growth driving 'surge in demand'
Symbiosis Pharmaceutical Services is preparing for increasing growth in the outsourcing sector with “a major investment” at its sterile filling facility underway and a recent hire in the US.
Q&A
Symbiosis Pharmaceutical Services is preparing for increasing growth in the outsourcing sector with “a major investment” at its sterile filling facility underway and a recent hire in the US.
Slovakian CDMO Saneca Pharma will make more than 20 generic products for Xantis after selling the registration dossiers to the Swiss firm.
GSK will pump £275m ($360m) into its UK manufacturing network and says the country has a “leading position in life sciences” despite the recent Brexit vote.
BASF has said it saw lower demand for its remaining active pharmaceutical ingredients (APIs) in the second quarter.
While the industry has made progress in advancing diversity in clinical trials, greater expectations may be forthcoming.
Crown Bioscience has expanded its San Diego facility to create its US Center of Excellence for Oncology in order to support increasing demand for oncology research studies.
Inovio Pharmaceuticals and GeneOne Life Science have dosed the first patient in the multi-center, phase I clinical trial of the companies’ Zika vaccine.